Synthesis of 2-Substituted Pyrazolo[1,5-a]pyridines through Cascade Direct Alkenylation/Cyclization Reactions

Organic Letters

Volumn 12, Issue 3, 2010, Pages 516-519

  Mousseau, James J ^a   Fortier, Angélique ^a   Charette, André B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; PALLADIUM; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; SILVER;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CYCLIZATION; SYNTHESIS;

ALKENES; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; CYCLIZATION; MOLECULAR STRUCTURE; PALLADIUM; PYRAZOLES; PYRIDINES; SILVER;

EID: 75749109336     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol902710f     Document Type: Article

References (46)

1. (a) Zheng, G.; Dwoskin, L. P.; Deaciuc, A. G.; Zhu, J.; Jones, M. D.; Crooks, P. A. Bioorg. Med. Chem. 2005, 13, 3899.
2. (b) Wilson, K. J.; van Niel, M. B.; Cooper, L.; Bloomfield, D.; O'Connor, D.; Fish, L. R.; MacLeod, A. M. Bioorg. Med. Chem. Lett. 2007, 17, 2643.
3. (c) Campeau, L.-C.; Fagnou, K. Chem. Soc. Rev. 2007, 36, 1058.
4. (d) Laird, T. Org. Process Res. Dev. 2006, 10, 851.
5. (a) Lober, S.; Hubner, H.; Gmeiner, P. Bioorg. Med. Chem. Lett. 2002, 12, 2377.
6. (b) Hasen, J. B.; Weis, J.; Suzdak, P. D.; Eskesen, K. Bioorg. Med. Chem. Lett. 1994, 4, 695.
7. (c) Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. J. Med. Chem. 2002, 45, 4594.
8. (a) Johns, B. A.; Gudmundsson, K. S.; Turner, E. M.; Allen, S. H.; Samano, V. A.; Ray, J. A.; Freeman, G. A.; Boyd, F. L., Jr.; Sexton, C. J.; Selleseth, D. W.; Creech, K. L.; Moniri, K. R. Bioorg. Med. Chem. 2005, 13, 2397.
9. (b) Akahane, A.; Katayama, H.; Mitsunaga, T.; Kato, T.; Kinoshita, T.; Kita, Y.; Kusunoki, T.; Terai, T.; Yoshida, K.; Shiokawa, Y. J. Med. Chem. 1999, 42, 779.
10. (c) Kuroda, S.; Akahane, A.; Itani, H.; Nishimura, S.; Durkin, K.; Kinoshita, T.; Tenda, Y.; Sakane, K. Bioorg. Med. Chem. Lett. 1999, 9, 1979.
11. For selected examples of synthesis of 3-substituted pyrazolo[1,5a] pyridines, see: (a) Lober, S.; Hubner, H.; Gmeiner, P. Bioorg. Med. Chem. Lett. 1999, 9, 97.
12. (b) Stevens, K. L.; Jung, D. K.; Alberti, M. J.; Badiang, J. G.; Peckham, G. E.; Veal, J. M.; Cheung, M.; Harris, P. A.; Chamberlain, S. D.; Peel, M. R. Org. Lett. 2005, 7, 4753.
13. (c) Valenciano, J.; Cuadro, A. M.; Vaquero, J. J.; Builla, J. A.; Castaño, O. J. Org. Chem. 1999, 64, 9001.
14. (a) Takashi, T.; Haruki, S. J. Chem. Soc., Chem. Commun. 1980, 1109.
15. (b) Csanyi, D.; Hajos, G.; Riedl, Z.; Timari, G.; Bajor, Z.; Cochard, F.; Sapi, J.; Laronze, J.-Y. Bioorg. Med. Chem. Lett. 2000, 10, 1767.
16. Johns, B. A.; Gudmundsson, K. S.; Turner, E. M.; Allen, S. H.; Jung, D. K.; Sexton, C. J.; Boyd, F. L.; Peel, M. R. Tetrahedron 2003, 59, 9001.
17. (d) Nunez, A.; Garcia de Viedna, A.; Martinez-Barrasa, V.; Burgos, C.; AlvarezBuilla, J. Synlett 2002, 1093.
18. (e) Chen, Z.; Su, M.; Yu, X. Org. Biomol. Chem. 2009, 7, 4641.
19. For selected reviews, see: (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174.
20. (b) Miura, M.; Satoh, T. Top. Organomet. Chem. 2005, 14, 55.
21. (c) Satoh, T.; Miura, M. Chem. Lett. 2007, 36, 200.
22. (d) Campeau, L.-C.; Fagnou, K. Chem. Commun. 2006, 1253.
23. (e) Seregin, I. Y.; Gevorgyan, V. Chem. Soc. Rev. 2007, 36, 1173.
24. (f) Ellman, J. Science 2007, 316, 1131.
25. For direct functionalization of pyridiniums, see: (a) Kanyiva, K. S.; Nakao, Y.; Hiyama, T. Angew. Chem., Int. Ed. 2007, 46, 8872.
26. (b) Campeau, L.-C.; Rousseaux, S.; Fagnou, K. J. Am. Chem. Soc. 2005, 127, 18020.
27. (c) Nakao, Y.; Kanyiva, K. S.; Hiyama, T. J. Am. Chem. Soc. 2008, 130, 2448.
28. (d) Cho, S. H.; Hwang, S. J.; Chang, S. J. Am. Chem. Soc. 2008, 130, 9254.
29. (e) Leclerc, J.-P.; Fagnou, K. Angew. Chem., Int. Ed. 2006, 45, 7781.
30. (f) Schipper, D. J.; El-Salfiti, M.; Whipp, C. J.; Fagnou, K. Tetrahedron 2009, 65, 4977.
31. Legault, C. Y.; Charette, A. B. J. Org. Chem. 2003, 68, 7119.
32. Legault, C. Y.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 6360.
33. (a) Legault, C. Y.; Charette, A. B. J. Am. Chem. Soc. 2005, 127, 8966.
34. (b) Legault, C. Y.; Charette, A. B. Heterocycles 2008, 76, 1271.
35. (a) Larivée, A.; Mousseau, J. J.; Charette, A. B. J. Am. Chem. Soc. 2008, 130, 52.
36. (b) Mousseau, J. J.; Larivée, A.; Charette, A. B. Org. Lett. 2008, 10, 1641.
37. For examples of cascade processes, see: (a) Tietze, L. F. Chem. Rev. 1996, 96, 115.
38. (b) Parsons, P. J.; Perkett, C. S.; Shell, A. J. Chem. Rev. 1996, 96, 195.
39. (c) Tourée, B. B.; Hall, D. G. Chem. Rev. 2009, 109, 4439.
40. (a) Mousseau, J. J.; Bull, J. A.; Charette, A. B. Angew Chem., Int. Ed. 2010, ASAP (DOI: 10.1002/anie.200906020).
41. (b) Bull, J. A.; Mousseau, J. J.; Charette, A. B. Org. Lett. 2008, 10, 5485.
42. 1H NMR.
43. For a discussion on CMD pathways, see: (a) Cárdenas, D. J.; MartínMatute, B.; Echavarren, A. M. J. Am. Chem. Soc. 2006, 128, 5033.
44. (b) García-Cuadrado, D.; Braga, A. A. C.; Maseras, F.; Echavarren, A. M. J. Am. Chem. Soc. 2006, 128, 1066.
45. (c) Lafrance, M.; Rowley, C. N.; Woo, T. K.; Fagnou, K. J. Am. Chem. Soc. 2006, 128, 8754.
46. (d) Gorelsky, S. I.; Lapointe, D.; Fagnou, K. J. Am. Chem. Soc. 2008, 130, 10848.